|
|

Title: Delayed release coated tablet of bupropion
hydrochloride
United States Patent: 6,143,327
Inventors: Seth; Pawan (Irvine, CA)
Assignee: Pharma Pass LLC (Irvine, CA)
Appl. No.: 459459
Filed: December 13, 1999
Abstract
The invention provides a delayed release coated tablet, free of
stabilizer and free of pore-forming agent comprising: (i) a core
consisting essentially of bupropion hydrochloride, a binder and a
lubricant; and (ii) a first coating consisting essentially of a
water-insoluble, water-permeable film-forming polymer, a plasticizer and a
water-soluble polymer; and (iii) a second coating consisting essentially
of a methacrylic polymer and a plasticizer therefor.
SUMMARY OF THE INVENTION
The invention provides a delayed release coated tablet comprising:
(i) a core comprising bupropion hydrochloride and conventional excipients,
free of stabilizer; and
(ii) a first coating consisting essentially of a water-insoluble,
water-permeable film-forming polymer, a plasticizer and a water-soluble
polymer,
(iii) a second coating consisting essentially of a methacrylic polymer and
a plasticizer therefor.
The invention thus provides a new bupropion hydrochloride delayed release
composition under the form of a coated tablet free of stabilizer of any
kind including those with acidic pH or with antioxidant properties. Also,
the delayed release is obtained thanks to a semi-permeable release
coating, free of (monomeric) pore-forming agent.
The tablets of the invention exhibit specific dissolution profiles.
The invention also provides a tablet comprising the delayed release coated
tablet of the invention, coated with a bupropion hydrochloride immediate
release coating.
Claim 1 of 19 Claims
What is claimed is:
1. A delayed release coated tablet comprising:
(i) a core comprising bupropion hydrochloride and conventional excipients,
free of stabilizer; and
(ii) a first coating consisting essentially of a water-insoluble,
water-permeable film-forming polymer, a plasticizer and a water-soluble
polymer; and
(iii) a second coating consisting essentially of a methacrylic polymer and
a plasticizer therefor;
exhibiting a dissolution profile such that after 2 hours, from 0 up to 30%
of the bupropion hydrochloride is released, after 4 hours, from 3 to 22%
of the bupropion hydrochloride is released, after 6 hours, from 15 to 38%
of the bupropion hydrochloride is released, after 8 hours, more than 40%
of the bupropion hydrochloride is released.
____________________________________________
If you want to learn more
about this patent, please go directly to the U.S.
Patent and Trademark Office Web site to access the full
patent.
|